US FDA - Approves Isembyld For Spinal Muscular Atrophy In Patients Aged 2 Years And Older
Scholar Rock Holding Corporation NASDAQ:SRRK
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.